Does Depression Speed Up ASCVD Onset and Treatment? - Medscape Patients with depression may develop atherosclerotic cardiovascular disease earlier and start treatment more often than those without depression but achieve similar cholesterol control, a study finds
Low-Dose Colchicine Approved for CVD: Now What? - Medscape The recent US approval of a new low dose of colchicine 0 5 mg (Lodoco; Agepha Pharma) with a broad indication for use in atherosclerotic cardiovascular disease (ASCVD) represents a completely new
Lp (a): Aiming at a Moving Target, Waiting for Ammunition Patients in the study — which used > 70 mg dL (or 150 nmol L) as a threshold for predicting ASCVD complications — with peripheral artery disease and elevated Lp (a) were at 57% greater risk